Myriad™ Augmented Soft Tissue Reconstruction Registry (MASTRR)
Registry of Myriad™ Utilization in Soft Tissue Reconstruction Procedures
Sponsor: Aroa Biosurgery Limited
Listed as NCT05243966, this observational or N/A phase trial focuses on Abdominal Wound Dehiscence and Anal Fistula and remains actively recruiting participants. Sponsored by Aroa Biosurgery Limited, it has been updated 12 times since 2022, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Apr 2025 — Feb 2026 [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Sep 2023 — Nov 2023 [monthly]
Recruiting
-
Jul 2023 — Sep 2023 [monthly]
Recruiting
-
Jan 2023 — Jul 2023 [monthly]
Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Recruiting
-
Apr 2022 — Jun 2022 [monthly]
Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Recruiting
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aroa Biosurgery Limited
For direct contact, visit the study record on ClinicalTrials.gov .